BTXA (lanbotulinumtoxinA) / Sinopharm  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BTXA (lanbotulinumtoxinA) / Sinopharm
NCT06410859: Botulinum Toxin Type A for Injection (HengLi®) in the Treatment of Trigeminal Neuralgia

Enrolling by invitation
2
240
RoW
Botulinum Toxin Type A for Injection,also known as "HengLi®"
LKGS_277
Trigeminal Neuralgia
06/26
06/26

Download Options